- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01382771
Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
A Randomized, Double-Blind, Placebo Controlled Perspective Study of Intraarticular Lumbar Zygapophysial Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
연구 개요
상태
정황
상세 설명
Subjects will have failed conservative treatment, including, but not limited to oral medications, physical therapy, chiropractic treatment, and/or alternative medicine. They will be evaluated by a spine specialist in the Spine Division of the Department of Orthopaedics and will be schedule for a medial branch block as standard of care. As part of usual and standard care, patients will undergo lumbar medial branch blocks for diagnosis of zygapophysial joint pain.
Patients who obtain ≥ to 80% relief of their index pain with a first set of lumbar medial branch blocks will be offered the opportunity for possible inclusion in the study if they are scheduled to receive a second medial branch block. The definition of a positive response to MBB's is an 80% reduction in pain (by change in NPR scores or estimated patient improvement) AND the restoration of the ability to perform at least one previously painful posture, movement, or activity without increase in pain, during the anesthetic phase of the blocks. If subjects are unable to render NPR scores or percentage estimate of improvement, then a 5 point global perception of effect tool will be used.
연구 유형
등록 (실제)
단계
- 초기 1단계
연락처 및 위치
연구 장소
-
-
Florida
-
Gainesville, Florida, 미국, 32607
- UF & Shands Orthopaedics and Sports Medicine Institute
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Low back pain episode greater than six months in duration
- NPR pain scale score three day average and present pain of at least four/ten at baseline (index pain)
- Previous medial branch block providing >80% pain relief for current painful episode
- Subject must be scheduled to undergo a second medial branch block for their back pain
Exclusion Criteria:
- Litigation
- Those seeking new or increased long-term remuneration
- Leg pain greater than back pain
- Radicular pain or evidence of neurological compromise in the lower limbs
- Those unable to read English and complete the assessment instruments
- Systemic inflammatory arthritis (e.g. rheumatoid, lupus)
- Addictive behavior, severe clinical depression or psychotic features. The subjects will be identified at the sole discretion of the PI who per the current standard of care will consent the potential subjects to the study
- Significant lower extremity pathology that affects gait
- Sustained cervical or thoracic pain that is present at a level >3/10 on NPR
- Possible pregnancy or other reason that precludes the use of fluoroscopy
- Significant scoliosis
- Radicular/neurological deficits or focal disc herniation and/or stenosis, with correlating radicular symptoms
- Contra-indication to corticosteroid, including known allergies or sensitivities
- History of prior epidural spinal injections relieving their current pain, or prior lumbar surgery.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: Intra-articular corticosteroid injection
Intra-articular corticosteroid injection in conjunction with confirmatory anesthetic medial branch blocks
|
Intra-articular injection of 0.5 cc triamcinolone acetonide (40 mg/cc) within each joint
|
위약 비교기: Intra-articular saline injection
Intra-articular saline injections with confirmatory anesthetic medial branch blocks
|
Intra-articular injection of 0.5 cc normal saline in each joint
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Numeric Pain Rating (NPR) or patient estimation of improvement, >80% pain reduction
기간: Hourly for 6 hours post injections
|
A positive response is defined as are ≥ 80% reduction in pain (by change in NPR scores or estimated patient improvement) AND the restoration of the ability to perform at least one previously painful posture, movement, or activity without increase in pain, during the anesthetic phase of the blocks.
|
Hourly for 6 hours post injections
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Numeric Pain Rating (NPR) Daily diary
기간: reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
The patient will be instructed to maintain a pain diary that records the degree and duration of any relief.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
Oswestry Disability Index (ODI)
기간: 6 weeks, 3 months, 6 months, 12 months
|
Patient will complete ODI at the follow-up intervals.
|
6 weeks, 3 months, 6 months, 12 months
|
Standard Form 36 (SF-36), General Health Survey
기간: 6 weeks, 3 months, 6 months, 12 months
|
Patient will complete the SF-36 at the follow-up intervals.
The SF-36 is a self-administered, generic, general health survey consisting of 36 questions.
The questions focus on the functional health and well being of the subject completing the form.
|
6 weeks, 3 months, 6 months, 12 months
|
Daily Work History Log
기간: reviewed at the 6 weeks, 3months, 6 months, 12 months follow-up
|
Patient will keep a Work History Log during participation.
The Log should indicate the daily work activities of the subject.
|
reviewed at the 6 weeks, 3months, 6 months, 12 months follow-up
|
Daily Analgesic Use Log
기간: reviewed at 6 weeks, 3 months, 6 months, 12 months
|
Patient will keep a Daily Analgesic Use Log during participation.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months
|
Ancillary Treatment Log
기간: reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
Patient will keep an Ancillary Treatment Log during participation.
This log will indicate any outside medical care, additional medial branch blocks or radiofrequency neurotomy treatments.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
공동 작업자 및 조사자
수사관
- 수석 연구원: D. J. Kennedy, M.D., UF Department of Orthopaedics and Rehabilitation
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 319-2010
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
하부 요통에 대한 임상 시험
-
FibroGenAstraZeneca; Astellas Pharma Inc종료됨기본 MDS(Very Low, Low 또는 Intermediate IPSS-R with미국, 호주, 벨기에, 독일, 이스라엘, 이탈리아, 대한민국, 러시아 연방, 스페인, 영국, 프랑스, 칠면조, 캐나다, 덴마크, 인도, 폴란드
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)완전한
-
Eisai Inc.완전한LEC(Low Emetogenic Chemotherapy)를 받기 위해 확인된 악성 질환이 있는 환자 또는 LEC의 마지막 주기 동안 최소한 메스꺼움 및 구토를 경험한 환자미국
Intra-articular corticosteroid injection에 대한 임상 시험
-
Procare Health Iberia S.L.완전한골관절염, 고관절 | 골관절염 엄지 | 골관절염 발목스페인